The FDA has approved Restylane Lyft with lidocaine for augmentation of the chin region for adults aged 21 years and older with mild to moderate chin retrusion, manufacturer Galderma announced in a ...
This approval is based on results showing the safety and effectiveness of Restylane Lyft in enhancing the chin profile, with high patient satisfaction and long-lasting results 1,2 Restylane Lyft is ...
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it presented new data from its Injectable Aesthetics portfolio and pipeline at the American Society for ...
THURSDAY, Oct. 2, 2025 (HealthDay News) -- Hyaluronic acid (HA) fillers restore facial volume and fullness as seen in novel metrics and patient-reported outcome (PROs), according to a study published ...
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Restylane Lyft with Lidocaine for ...
“This approval reinforces our commitment to advancing our Injectable Aesthetics portfolio – the broadest on the market – to meet the diverse needs of patients. By expanding how innovations like ...
Galderma, the pure-play dermatology category leader, today announced that the United States (US) Food and Drug Administration (FDA) has approved Restylane Lyft with Lidocaine for augmentation of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback